• Media releases
  • Features
  • Gallery
  • Quick facts
  • Contact
  • About Medibank
  • Investor Centre
  • ASX Releases

    Medibank appoints Gerard Dalbosco as a non-executive director

    Gerard Dalbosco

    Medibank today announced the appointment of Gerard Dalbosco as a non-executive director with effect from 21 May 2021.

    Medibank Chairman Mike Wilkins said the Board was delighted to welcome Mr Dalbosco.

    “We are very pleased that Gerard has accepted our invitation to join the Board. Gerard’s management and governance experience is extensive, as reflected in the roles he has held. He brings to the Board strong financial acumen and experience in delivering for customers, and we look forward to the significant contribution he will make to Medibank,” Mr Wilkins said.

    Mr Dalbosco was a Partner of EY until September 2020, where he held a number of senior leadership roles, including Asia Pacific Managing Partner – Markets and Co-Deputy CEO where he led EY’s client-serving activities across the Asia-Pacific market; Oceania Managing Partner and CEO where he was responsible for EY’s Oceania business, Oceania Managing Partner of Transaction Advisory Services where he was responsible for EY’s Transaction Advisory Services business across Oceania, and most recently Melbourne Managing Partner, where he led a large team of Partners and staff and was responsible for EY’s go-to-market and client service strategies, as well as its involvement in the broader Melbourne community.

    Mr Dalbosco has previously held roles as Director and Chair of the Finance & Audit Committee of Mercy Health & Aged Care, Director and member of the Finance Committee of Berry Street Victoria, Co-Deputy Chair and Chair of the Finance Committee of the Committee for Melbourne and Chair of the National Gallery of Victoria’s Business Council.

    Mr Dalbosco is a Fellow of the Institute of Chartered Accountants in Australia and a Fellow of the Financial Services Institute of Australasia.

    Mr Dalbosco will join the Audit Committee and the Risk Management Committee on his appointment. Effective 21 May 2021, Mike Wilkins will cease to be a member of the Audit Committee and Risk Management Committee, and will become a member of the People & Remuneration Committee.

    This document has been authorised for release by the Medibank Board.

    For further information please contact:
    For media:
    Emily Ritchie
    Senior Executive, External Affairs
    M: +61 429 642 418
    Email: Emily.Ritchie@medibank.com.au

    For investors/analysts:
    Colette Campbell
    Senior Executive, Investor Relations
    T: +61 475 975 770
    Email: investor.relations@medibank.com.au

    For a complete list of all ASX announcements, please visit our Investor Centre.

    Keep reading